Literature DB >> 30460611

Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis.

Jia Li1, Ruijuan Liu2, Shifeng Tang2, Fubin Feng2, Cun Liu3, Lu Wang3, Wenge Zhao1, Tingting Zhang3, Yan Yao1, Xue Wang4, Changgang Sun5.   

Abstract

PURPOSE: The risks of gynecologic cancer have not been well established in women with endometriosis. The objective of the present study was to investigate the influence of endometriosis on the risk for three gynecologic cancer (ovarian cancer, endometrial cancer and cervical cancer).
METHODS: We gathered updated evidence about the risk relationship between endometriosis and gynecologic cancers by conducting a comprehensive search of several medical literature electronic databases, including PubMed, Embase and the Cochrane Library. The design and quality of all studies were evaluated using the Newcastle-Ottawa Scale (NOS), and a random-effects model was used to calculate pooled risk ratio (RR).
RESULTS: Of the 8538 articles our search produced, we selected 25 qualified studies, including 16 cohort studies and 9 case-control studies. Patients with endometriosis had both an increased risk of ovarian cancer [RR  1.964; 95% CI (1.685, 2.290)]. The risk of endometrial cancer (EC) is not necessarily higher in patients with endometriosis [RR 1.176, 95% CI (0.878, 1.575)]. Endometriosis was not associated with an increased risk for cervical cancer (CC) [RR 0.670, 95% CI (0.537, 0.838)].
CONCLUSIONS: Patients with endometriosis need to be closely observed and rechecked regularly to prevent malignant changes.

Entities:  

Keywords:  Cervical cancer; Endometrial cancer; Endometriosis; Gynecological cancer; Ovarian cancer; Risk

Mesh:

Year:  2018        PMID: 30460611     DOI: 10.1007/s00404-018-4968-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  10 in total

Review 1.  Review of Mendelian Randomization Studies on Endometrial Cancer.

Authors:  Jian-Zeng Guo; Qi-Jun Wu; Fang-Hua Liu; Chang Gao; Ting-Ting Gong; Gang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-09       Impact factor: 6.055

Review 2.  Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature.

Authors:  Eilbhe Whelan; Ilkka Kalliala; Anysia Semertzidou; Olivia Raglan; Sarah Bowden; Konstantinos Kechagias; Georgios Markozannes; Sofia Cividini; Iain McNeish; Julian Marchesi; David MacIntyre; Phillip Bennett; Kostas Tsilidis; Maria Kyrgiou
Journal:  Cancers (Basel)       Date:  2022-05-30       Impact factor: 6.575

3.  Markers of Local and Systemic Estrogen Metabolism in Endometriosis.

Authors:  Essam R Othman; Ahmad Abo Markeb; Maha Y Khashbah; Ibrahim I Abdelaal; Tarek T ElMelegy; Ahmed N Fetih; Lisette E Van der Houwen; Cornelis B Lambalk; Velja Mijatovic
Journal:  Reprod Sci       Date:  2020-11-20       Impact factor: 3.060

4.  Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus.

Authors:  Dylan M Glubb; Tracy A O'Mara; Pik Fang Kho; Sally Mortlock; Peter A W Rogers; Dale R Nyholt; Grant W Montgomery; Amanda B Spurdle
Journal:  Hum Genet       Date:  2021-07-15       Impact factor: 4.132

5.  Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study.

Authors:  Chen-Yu Huang; Wen-Hsun Chang; Hsin-Yi Huang; Chao-Yu Guo; Yiing-Jenq Chou; Nicole Huang; Wen-Ling Lee; Peng-Hui Wang
Journal:  Clin Epidemiol       Date:  2020-06-18       Impact factor: 4.790

6.  Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials.

Authors:  Wenbin Meng; Na Ta; Fei Wang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 7.  Endometriosis and ovarian cancer risk, an epigenetic connection.

Authors:  Sarah Brunty; Brenda Mitchell; Nadim Bou-Zgheib; Nalini Santanam
Journal:  Ann Transl Med       Date:  2020-12

8.  Clinical Efficacy of Treating Endometrial Cancer with Xiaoaiping Tablets under Comprehensive Nursing Intervention and Their Effect on Quality of Life.

Authors:  Juan Wang; Qingyan Liu; Jianping Li; Dan Nie; Daiying Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-13       Impact factor: 2.629

Review 9.  The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art.

Authors:  Dorota Suszczyk; Wiktoria Skiba; Joanna Jakubowicz-Gil; Jan Kotarski; Iwona Wertel
Journal:  Cells       Date:  2021-03-18       Impact factor: 6.600

10.  Genetic Contribution of Endometriosis to the Risk of Developing Hormone-Related Cancers.

Authors:  Aintzane Rueda-Martínez; Aiara Garitazelaia; Ariadna Cilleros-Portet; Sergi Marí; Rebeca Arauzo; Jokin de Miguel; Bárbara P González-García; Nora Fernandez-Jimenez; Jose Ramon Bilbao; Iraia García-Santisteban
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.